Vectorite Biomedical uses the HAEMONETICS MCS+ to collect high-concentration immune cells for customers by professional cryopreservation technology that using antifreeze reagents and programmed cooling system to store customers' immune cells in a -180°C gas-phase liquid nitrogen environment. The frozen immune cells can maintain a cell survival rate of over 95%.
Since 2021, Vectorite Biomedical has cooperated with twelve hospitals in Taiwan to obtain DC(dendritic cell) and NK(natural killer cell) treatment technology approval, providing more protection for our cell storage customers and supporting measures and options for those who may need to cell therapy in the future.
Vectorite Asia-Pacific research center(GTP No. TP109C016)
ISO 9001:2008
Infectivity testing
Immune cell surface specific antigen analysis
Immune cell group identification
Immune cell counting and survival rate analysis
Immune cell sterility testing
ISO17025
ISO15189
Annual sampling of control groups for viability analysis ensures the stability of cell storage environments and guarantees future clinical applications.
Bei Wang, Shuhong Han, Lily Lien, Lung-Ji Chang (2009) Lentiviral calnexin-modified dendritic cells promote expansion of high-avidity effector T cells with central memory phenotype. Blackwell Publishing Ltd, Immunology, 128, 43–57
Lujia Dong, Zhi-Yong Gao, Lung-Ji Chang, Yin Liang, Xi-You Tan, Jin-Hong Liu, Xin-Jian Yu, Fu-hung Yang, Yi Xie and Dao-Pei Lu (2010) Adoptive Transfer of Cytomegalovirus/Epstein-Barr Virus-specific Immune Effector Cells for Therapeutic and Preventive/Preemptive Treatment of Pediatric Allogeneic Cell Transplant Recipients. J Pediatr Hematol Oncol Volume 32(1):e31-7
I403332: A Method to produce immune cells and induce immune effector cells.
CN101928695B: Method for producing immune cells and method for inducing immune effector cells.
